3 years ago

A "Protective Umbrella" Nanoplatform for Loading ICG and Multi-modal Imaging-guided Phototherapy.

Du, Sun, Zhou, Meng, Chen, Ye
In order to prevent the aggregation of ICG and enhance its stability, a novel nanoplatform (TiO2:Yb,Ho,F-β-CD@ICG/HA) was designed for NIR-induced phototherapy along with multi-mode imaging(UCL/MRI/Flu). In this nanosysytem: TiO2:Yb,Ho,F was used as upconversion materials and applied in vivo for the first time; β-CD was acted as a "protective umbrella" to load separated ICG and avoid the low phototherapy efficiency because of its aggregation; HA was the capping agent of β-CD to prevent ICG unexpected leaking and a target to recognize CD44 receptor. The nanosystem exhibited excellent size(~200 nm) and photo- and thermal-stability, preferable reactive oxygen yield and temperature response (50.4 °C) under 808 nm laser. It could efficiently targeted and suppressed tumor growth. The imaging ability (UCL/MRI) of TiO2:Yb,Ho,F could facilitate diagnose the tumor, especially for deep tissues. Altogether, Our work successfully improved the phototherapy efficacy through incorporating the ICG into the cavity of β-CD and applied TiO2:Yb,Ho,F for upconversion imaging in vivo.

Publisher URL: http://doi.org/10.1016/j.nano.2017.09.009

DOI: 10.1016/j.nano.2017.09.009

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.